Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexamethasone in Herpes Simplex Virus Encephalitis
2024-515985-16-00Phase 3Completed
- Sponsor
- CHU Grenoble Alpes
- Start
- Sep 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of dexamethasone in herpetic meningoencephalitis (HME) (2 arms), sponsored by CHU Grenoble Alpes. Primary endpoint: Verbal memory score at 6 months. Started Sep 2024; status: completed.
02
Drugs
dexamethasone
03
Conditions
herpetic meningoencephalitis (HME)
Beyond the preview
Go deeper on 2024-515985-16-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-515985-16-00.